Oxford Properties kicks off €1.4b European life sciences strategy with Cambridge AstraZeneca HQ

Oxford Properties, the property arm of Canadian pension fund giant OMERS, has expanded its life sciences platform with its first European acquisition involving the AstraZeneca headquarters in Cambridge, UK.

Would you like to read more? Log in first (top right of the screen) or take a trial.